Antidepressants and sexual dysfunction: mechanisms and clinical implications
Anita H Clayton1, Harry A Croft, Lata Handiwala
1University of Virginia School of Medicine, Charlottesville, VA. ahc8v@virginia.edu.
Postgraduate Medicine
|April 2, 2014
Summary
Antidepressant medications can cause sexual side effects (SD). Some antidepressants, like bupropion and mirtazapine, are linked to less SD than SSRIs/SNRIs and may treat antidepressant-induced sexual dysfunction.
Area of Science:
- Psychiatry
- Pharmacology
- Sexual Medicine
Background:
- Depression affects 6.7% of Americans annually, leading to widespread antidepressant use.
- Depression and its treatments are linked to various sexual dysfunctions (SD) in men and women.
- SD is a common reason for patients discontinuing depression treatment.
Purpose of the Study:
- To guide physicians in managing patients with both depression and SD.
- To provide a multidisciplinary approach for treating SD in depressed patients.
- To review the impact of depression treatments on sexual function.
Main Methods:
- Review of articles published within the last 10 years.
- Focus on adult patients with SD and depression.
- Emphasis on the relationship between depression treatments and SD.
Main Results:
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) are associated with SD.
- Bupropion, mirtazapine, nefazodone, and vilazodone are linked to less SD compared to SSRIs.
- These alternative antidepressants can be used to treat SD caused by SSRIs/SNRIs.
Conclusions:
- Different antidepressant classes have varying propensities for causing sexual side effects.
- Understanding these differences is crucial for effective depression management.
- Alternative antidepressants may offer a solution for patients experiencing SD.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Depressive Disorders: Etiology
884
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
884
G-protein Coupled Receptors
91.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
91.4K
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K


